All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...728Next →

hiv & aids news selected from other sources

  • Hepatitis C treatment
    National study finds life-threatening barriers in access to breakthrough drugs
    Eurekalert | 1 hour ago

    Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C, according to Lynn E. Taylor, M.D., director of The Miriam Hospital's HIV/Viral Hepatitis Coinfection Program. Taylor's team of researchers examined Medicaid policies for hepatitis C virus treatment using sofosbuvir and found that most should change policy to improve access to the treatment.

  • New and experimental hepatitis C treatment
    FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data
    Wall Street Journal (blog) | 16 hours ago

    Specifically, the groups hope to learn about different responses that different patients experienced during clinical trials. Tracy Swan of Treatment Action Group points to relapses in a Harvoni clinical trial that occurred only among African-Americans. The groups also want to perform an independent analysis of poor prognostic factors among people who were not cured in order to identify a patient profile.

  • Microbicides
    Researchers complete ASPIRE Phase III trial of vaginal ring for HIV prevention in women
    Eurekalert Medicine & Health | 17 hours ago

    In a first for HIV prevention, researchers have completed follow-up of participants in a pivotal Phase III trial that tested a vaginal ring for preventing HIV in women. The ring, which contains the ARV dapivirine, is meant to be worn for a month at a time. More than 2,600 African women took part in ASPIRE, one of two Phase III trials designed to support potential licensure of the ring. Results are expected early 2016.

  • Finance and funding
    Launch of innovative HIV prevention fund
    Public Health England press release | 29 June 2015

    Public Health England is encouraging all voluntary organisations to apply for national funding to enable innovative HIV (human immunodeficiency virus) projects across England.

  • Structural factors
    More secondary schooling reduces HIV risk
    Eurekalert Inf Dis | 29 June 2015

    Longer secondary schooling substantially reduces the risk of HIV infection -- especially for girls -- and could be a very cost-effective way to halt the spread of the virus, according to researchers from Harvard T.H. Chan School of Public Health. In a study in Botswana, researchers found that, for each additional year of secondary school, students lowered their risk of HIV infection by 8 percentage points about a decade later, from 25 percent to about 17 percent infected.

  • HIV prevention policy
    What Preventing HIV in Babies Can Tell Us about Preventing HIV in Adults
    BETA blog | 29 June 2015

    Between 1991 and 2010, a massively successful public health strategy reduced the number of babies born in the U.S. with HIV from over 1500 in a year to just over 150. Those engaged in the fight against HIV should look to and learn from the successes and experiences of perinatal HIV transmission prevention efforts.

  • Hepatitis C treatment
    Adding ribavirin to Harvoni for hepatitis C increases side effects but not efficacy
    HIVandHepatitis.com | 29 June 2015

    Combining sofosbuvir/ledipasvir (Harvoni) with ribavirin was associated with a greater likelihood of adverse events and laboratory abnormalities, but did not significantly increase the chances of sustained response for genotype 1 chronic hepatitis patients compared to sofosbuvir/ledipasvir alone.

  • PrEP
    Pride in London: NHS to come under pressure to provide 'miracle' HIV prevention pill
    The Independent | 27 June 2015

    Campaigners from the Terrence Higgins Trust will carry placards calling on the Government to have pre-exposure prophylaxis (PrEP) made freely available on the NHS as an HIV prevention strategy for gay men.

  • Pharmaceutical industry
    Bristol-Myers to stop new antiviral drug research
    Reuters | 26 June 2015

    Bristol-Myers Squibb said on Thursday that it would stop efforts to find new antiviral drugs and cut 100 related jobs. The company said it will also discontinue its Hepatitis B and HIV early programs.

  • How HIV causes disease
    Potential New HIV Therapy Seen in Component of Immune Cells
    Weill Cornell Medical College | 26 June 2015

    A research team led by Weill Cornell Medical College scientists has discovered a way to limit replication of the most common form of HIV at a key moment when the infection is just starting to develop. The study, published June 25 in Nature Communications, has shed light on a potential new element of human immunity against HIV-1 and could provide a powerful new strategy — perhaps as part of an HIV vaccine — to limit the severity of the disease.

← First12345...1060Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.